Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Meiji

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Meiji's Japan sales performance.

Gilead, Galapagos dip on mixed ulcerative colitis data

Gilead, Galapagos dip on mixed ulcerative colitis data

Filgotinib is already under regulatory review in the US, Europe and Japan as a treatment for rheumatoid arthritis, but Gilead and Galapagos will need to extend the use of the drug

Biopharma body welcomes EU-UK free trade agreement docs

Biopharma body welcomes EU-UK free trade agreement docs The UK seeks an FTA close to those agreed by the EU with Canada or Japan. ... union, and instead is seeking a free trade agreement (FTA) that “approximates very closely those the EU has agreed with Canada or Japan”.

Novartis claims EU approval for SMA gene therapy Zolgensma

Novartis claims EU approval for SMA gene therapy Zolgensma Japan in March where it has been given a lower price of around $1.55m dollars.

FDA clears phase 2 COVID-19 trial of ViralClear’s merimepodib

FDA clears phase 2 COVID-19 trial of ViralClear’s merimepodib Aside from an emergency use authorisation for remdesivir and hydroxychloroquine/chloroquine in the US and a similar approval for remdesivir in Japan, there are no approved therapeutics options for the treatment

Gilead signs generic drugmaker deals to boost remdesivir supply

Gilead signs generic drugmaker deals to boost remdesivir supply Companies not on the list include Brazil, China, Mexico and Russia, as well as the US and Japan which have already authorised the drug for use.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses...
OPEN Health use PR to support clinical trial recruitment
International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2...
Covid-19: what could it mean for the diabetic population?
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it...

Infographics